Methadone Market Size & Share, by Form (Oral Solution, Tablets, Intravenous Injections); Application (Pain Treatment, Detoxification, Maintenance Therapy, Addiction Rehabilitation); End-user (Hospital, Rehab Centers, Drug Stores, Research Centers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 3793
  • Published Date: Apr 26, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2023-2035

Methadone Market Size is estimated to reach USD 250 million by the end of 2035, growing at a CAGR of 7% during the forecast period, i.e., 2023-2035. The growth of the market is associated with the increasing prevalence of pain after a post-surgery treatment or treatment. The demand for methadone is driven by these pain-related issues. Methadone helps in reducing the deadly pain that takes place after a therapeutic or post-surgery treatment. As per a report from the U.S. Department of Health and Human Services, in 2019, around 20% of U.S. adults suffered from chronic diseases out of which 4% of adults felt chronic pain from the disease very hard.

Additionally, the growing number of people addicted to multiple opioids such as heroin, and morphine is also a significant factor that is anticipated to drive the growth of this market in the forecast period. Methadone helps an individual get rid of the addiction or dependency on heroin, morphine, or any other prescription painkillers. As per National Survey on Drug Use and Health, indicates that around 6 million adults globally are addicted to Heroin.


Methadone Market
Get more information on this report: Request Free Sample PDF


Methadone Market: Key Insights

Base Year

2022

Forecast Year

2023 - 2035

CAGR

~7%

Base Year Market Size (2022)

~USD 150 million

Forecast Year Market Size (2035)

~USD 250 million

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Methadone Sector: Growth Drivers and Challenges

Market-Growth-Drivers

Growth Drivers

  • Increasing Application in Heroin Addiction Treatment – Methadone is widely used to reduce addiction or dependency on heroin, morphine, or prescription painkillers. Therefore, increasing application in heroin addiction treatment is one of the growth drivers of this market. As per the latest World Drug Report, every year around 35 million people suffer from Drug disorders.
  • Increasing Geriatric Population – As discussed in the above parts, methadone is a drug or medication that helps in reducing pain after a post-surgery or therapeutic treatment. Also, the medication patients recover from any kind of chronic disease if they are suffering through it. Many times it is seen that people who are above the age of 60 or who belong to the geriatric population end up suffering from chronic disease. Therefore, the increasing geriatric population is driving the growth of this market.  As per a report from the World Health Organization, the geriatric population is expected to become double.
  • Growing Development and Launches in the Field of Methadone – Recently, lots of development and launch have taken place in the field of methadone. Elite Pharmaceutical and Glenmark Pharmaceutical collaborated and introduced methadone hydrochloride tablets in the market that will be used to reduce opioid abuse in patients. 
  • Growing Existence of Chronic Diseases – In the United States around 45% population of the region suffers from chronic diseases.

Challenges

  • Side Effects of Methadone – The rise in side effects, such as constipation, nausea, and vomiting, among others, is one of the factors that is expected to restrict the expansion of the methadone market. Furthermore, the market is likely to face obstacles because of strict government approval.
  • Addictive Nature of Opioids
  • Circulation of Generic Methadone


Methadone Segmentation

The global market is segmented and analyzed for demand and supply by form into oral solutions, tablets, intravenous injections, and others. Out of this, the oral solution segment is anticipated to account for the largest market share in the forecast period. Methadone oral solution is liquid methadone that can be prescribed for pain management and addiction treatment. They come in different strengths and can be prescribed to patients who have difficulty swallowing tablets. The growth of the market can be attributed owing to the growing geriatric population suffering from chronic diseases who prefer to consume methadone in the form of an oral solution. This is anticipated drive the growth of this segment in the forecast period. For instance, as per the World Health Organization report, by 2050 the geriatric population is anticipated to grow triple from 146 million to 438 million. 

The global methadone market is segmented and analyzed for demand and supply by end users in hospitals, rehab centers, drug stores, research centers, and others. The rehab center segment is estimated to hold the largest market share in the forecast period. This is attributed owing to the number of people globally suffering from heroin, drug, and morphine addiction. To cure them this addiction rehab centers widely make use of this medication. As per data, more than 3 million people are of health conditions seeking the help of rehabilitation.

Our in-depth analysis of the global market includes the following segments:

     By Form

  • Oral Solution
  • Tablets
  • Intravenous Injections
  • Others

     By Application

  • Pain Treatment
  •  Detoxification
  • Maintenance Therapy
  •  Addiction Rehabilitation
  • Others

     By End User

  • Hospital
  • Rehab Centers
  • Drug Stores
  • Research Centers
  •  Others

 


Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Methadone Industry - Regional Synopsis

North American Market Forecast

The market in the North American region is anticipated to gain the largest market share throughout the forecast period on the back of the high demand for methadone in rehabilitation centers, backed by increasing cases of drug addiction in the region. According to the Centre for Disease Control and Prevalence (CDC) in 2019, 70,630 deaths were caused by drug overdose in the United States. Additionally, the increased prevalence of misery and the increase in substance abuse cases, have further fueled regional expansion. High distress is also associated with an increase in the number of patients using methadone to treat persistent post-operative pain.

APAC Market Statistics

On the other, the market in the Asia-Pacific region is expected to have significant growth in the forecast period. This is owing to the fact that India and China are countries that have high populations, especially geriatric ones. This indicates that people in these countries have chances to get affected by chronic diseases which in turn will drive the growth of the market in the upcoming time.

Europe Market Forecast

The market in the Europe region is estimated to have steady growth in the forecast period. This is ascribed owing to the high obtainment of analgesics. Factors such as the high population suffering from chronic and respiratory diseases in this region are driving the growth of this market in the European region. As discussed in the previous part that methadone helps to treat quite a lot of chronic diseases as well as gives relief to deadly pain the body is suffering from.

Research Nester
Methadone Market Size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Methadone Landscape

top-features-companies
    • Eli Lilly and Company
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Sanofi S.A.
    • Hikma Labs Inc.
    • Mallinckrodt Pharmaceuticals
    • Siegfried Holding AG
    • Johnson Matthey
    • Gilead Sciences, Inc.
    • BioControl Medical
    • Tianjin Central Pharmaceutical Industry Co., Ltd.

In-the-news

In The News

  • Novartis AG will present more than 150 abstracts that highlight the outcomes of research efforts to target disease pathways. These abstracts include updated data in ALK+ non-small cell lung cancer and the first-ever presentations of key data in polycythemia vera, multiple myeloma (blood), and locally advanced or metastatic basal cell carcinoma (skin).
  • Siegfried Holding AG inaugurates a state-of-the-art Development Center for Drug Products in Barcelona, including dedicated facilities for highly potent Drug Products.  The Development Center provides a wide range of development services and flexible pilot capacities, strengthening Siegfried's global Drug Products network. The opening concludes the successful integration of the two pharmaceutical manufacturing sites in Spain which were acquired by Siegfried beginning of 2021.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 3793
  • Published Date: Apr 26, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The growing demand for methadone rehabilitation of heroin addicts is the major factor driving the growth of the methadone market.

The market is anticipated to attain a CAGR of 7% over the forecast period, i.e., 2023-2035.

Circulation of methadone and its addictive nature are the few factors likely to hamper market growth.

The market in North America is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Hikma Labs Inc., Mallinckrodt Pharmaceuticals, Siegfried Holding AG, Johnson Matthey, Gilead Sciences, Inc., Novartis AG, and many more.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by form, end user, region, and by application.

The rehab center sub-segment from the vehicle type segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Methadone Market Report Scope
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying